T1	Chemical	16 44	of erlotinib and bevacizumab
T2	Phenotype	54 60	PFS in
T3	Disease	75 95	EGFR -mutant NSCLC .
R1	increases	Arg1:T1	Arg2:T2
R2	treats	Arg1:T1	Arg2:T3
R3	isAssociatedWith	Arg1:T2	Arg2:T1
R4	isAssociatedWith	Arg1:T3	Arg2:T1
